We invite you to complete this short Consensus Survey in preparation for the MICROB-PREDICT Consensus Conference on Wednesday, 27 May 2026, during EASL Congress in Barcelona, Spain. Scope: Microbiome-based mechanisms and biomarkers for improved patient stratification and prediction of therapeutic…
We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology.
EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care. Through real-world experiences, the panel discusses how primary care professionals can integrate mo…
THRIVE ACTIVITIES AT EASL LIVER CANCER SUMMIT 2026 The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk populations, tumour-host molecular interactions, developing biomarkers for current therapies and identi…
The DECISION consortium has just published a fundamental study in the Journal of Hepatology on immune mechanisms predicting outcomes in patients with acutely decompensated cirrhosis (ADC). By analysing whole-blood RNA-sequencing (RNA-seq) data from over 1,200+ patients, researchers identified mal…
